2022
Corrigendum to “Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan” [Vaccine 33(47) (2015) 6479–6487]
Halasa N, Williams J, Faouri S, Shehabi A, Vermund SH, Wang L, Fonnesbeck C, Khuri-Bulos N. Corrigendum to “Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan” [Vaccine 33(47) (2015) 6479–6487]. Vaccine 2022, 40: 5537. PMID: 35965242, PMCID: PMC9371790, DOI: 10.1016/j.vaccine.2022.08.003.Peer-Reviewed Original Research
2015
Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan
Halasa N, Williams J, Faouri S, Shehabi A, Vermund SH, Wang L, Fonnesbeck C, Khuri-Bulos N. Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan. Vaccine 2015, 33: 6479-6487. PMID: 26314623, PMCID: PMC7115487, DOI: 10.1016/j.vaccine.2015.08.048.Peer-Reviewed Original ResearchMeSH KeywordsEpidemiological MonitoringFemaleHospitalsHumansInfantInfant, NewbornJordanMaleMass SpectrometryNasal MucosaPharynxPrevalenceProspective StudiesReal-Time Polymerase Chain ReactionRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsReverse Transcriptase Polymerase Chain ReactionRisk FactorsVitamin DConceptsRespiratory syncytial virusRSV-positive childrenVitamin D levelsD levelsRespiratory virusesRisk factorsMedical conditionsBurden of RSVOxygen useMedian vitamin D levelNasal/throat swabsRespiratory syncytial virus infectionCause of bronchiolitisHeel stick bloodSyncytial virus infectionLack of breastfeedingSupplemental oxygen useHigh viral loadFuture RSV vaccinesYoung childrenReal-time RT-PCRRSV hospitalizationRespiratory symptomsRSV vaccineAntiviral therapy